Article
Reversal of diabetes following transplantation of an insulin-secreting human liver cell line: Melligen cells
1 Jan 2015
Abstract excerpt
As an alternative to the transplantation of islets, a human liver cell line has been genetically engineered to reverse type 1 diabetes (TID). The initial liver cell line (Huh7ins) commenced secretion of insulin in response to a glucose concentration of 2.5 mmol/l. After transfection of the Huh7ins cells with human islet glucokinase, the resultant Melligen cells secreted insulin in response to glucose within the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
